The neuroprotective effect of losartan through inhibiting AT1/ASK1/MKK4/JNK3 pathway following cerebral I/R in rat hippocampal CA1 region
Autor: | Xiaojiang Sun, Zhi Geng, Jian-Liang Fu, Jia-Jun Yang, Tian-Ling Zhang |
---|---|
Rok vydání: | 2012 |
Předmět: |
Male
medicine.medical_specialty MAP Kinase Kinase 4 In Vitro Techniques MAP Kinase Kinase Kinase 5 Neuroprotection Losartan Receptor Angiotensin Type 1 Brain Ischemia Oligodeoxyribonucleotides Antisense Rats Sprague-Dawley Mitogen-Activated Protein Kinase 10 Physiology (medical) Internal medicine medicine Animals Immunoprecipitation Pharmacology (medical) ASK1 Protein kinase A Receptor CA1 Region Hippocampal Pharmacology Neurons Analysis of Variance Angiotensin II receptor type 1 biology Cell Death Dose-Response Relationship Drug Chemistry Original Articles Angiotensin II Mitochondria Rats Psychiatry and Mental health Disease Models Animal Endocrinology Neuroprotective Agents Mitogen-activated protein kinase Reperfusion Injury biology.protein cardiovascular system hormones hormone substitutes and hormone antagonists circulatory and respiratory physiology medicine.drug Signal Transduction |
Zdroj: | CNS neurosciencetherapeutics. 18(12) |
ISSN: | 1755-5949 |
Popis: | Summary Aims It has been well documented that angiotensin II type 1 (AT1) receptor blockers (ARBs) are known to attenuate neural damage and the c-Jun N-terminal protein kinase 3 (JNK3) pathway and caspase-3 signal are involved in neuronal cell death following cerebral ischemia/reperfusion (I/R). In this study, we first showed that losartan could protect neurons against cerebral I/R-induced injury. Methods Cerebral ischemia model was induced by four-vessel occlusion. Antisense oligodeoxynucleotides (ODNs) against AT1 receptor and losartan were used to detect whether the AT1 receptor implicated in cerebral I/R. Immunoprecipitation (IP) and immunoblotting (IB) were used to detect the interactions between β-arrestin-2 and AT1/apoptosis signal-regulating kinase 1 (ASK1)/MAP kinase kinase 4 (MKK4) signaling module following cerebral I/R. Results First, losartan decreased cerebral I/R-induced neuronal death. Second, losartan depressed the β-arrestin-2-assembled AT1/ASK1/MKK4 signaling module. Third, losartan depressed the activation of c-jun, JNK3, Bcl-2, caspase-3 and the release of cytochrome c from mitochondria to cytoplasm. Conclusion Taken together, losartan could attenuate neural damage following the cerebral I/R via inhibiting the β-arrestin-2-assembled AT1/ASK1/MKK4 signaling module and depressing the activation of c-jun, JNK3, and caspase-3 and the release of cytochrome c. |
Databáze: | OpenAIRE |
Externí odkaz: |